Search

Search Constraints

You searched for: Author/Creator Blum, William

Search Results

1. A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome. Issue 12 (19th September 2020)

4. Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia. Issue 16 (14th April 2017)

5. Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults. (23rd February 2013)

6. Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. Issue 4 (April 2015)

8. Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. Issue 9 (1st September 2016)

9. Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia. (1st August 2016)

10. Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia. Issue 9 (September 2013)